Sanofi stock at EUR 87.95, up 0.33% premarket
Published on 11/17/2026 at 08:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSanofi's Next Investor Dates
- Sanofi lists the Jefferies Global Healthcare Conference in London for Tuesday, November 17, 2026.
- The company's fourth-quarter and full-year 2026 results are scheduled for January 28, 2027.
Sanofi stock traded at 87.95 euros on Lang & Schwarz at 08:44 CET on Tuesday, November 17, 2026, 0.33 percent above the Xetra close of Monday, November 16.
Sanofi is a global pharmaceutical company focused on medicines and vaccines. Its investor-relations page lists the Jefferies Global Healthcare Conference in London for Tuesday, November 17, with Jean-François Toussaint, global head of research and development for vaccines, as speaker.
Sanofi also schedules its fourth-quarter and full-year 2026 results for January 28, 2027, giving investors the next major company reporting date.
The CAC 40 provides the relevant French-market context for Sanofi stock.
Disclaimer...
en | FR0000120578 | SANOFI S.A. | boerse | 70525462 | bgmi
